Merck KGaA (MKGAF)
163.26
+6.18
(+3.94%)
USD |
OTCM |
Apr 29, 16:00
Merck Price: 163.26 for April 29, 2024
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Apr 29, 2024 | 161.41 | 163.26 | 160.04 | 163.26 | 42.00 |
| Apr 26, 2024 | 166.52 | 166.52 | 157.08 | 157.08 | 82.00 |
| Apr 25, 2024 | 154.80 | 165.33 | 154.80 | 165.33 | 1092.00 |
| Apr 24, 2024 | 168.14 | 168.14 | 158.36 | 158.36 | 111.00 |
| Apr 23, 2024 | 160.50 | 160.50 | 160.50 | 160.50 | 18.00 |
| Apr 22, 2024 | 152.05 | 156.00 | 152.05 | 156.00 | 63.00 |
| Apr 19, 2024 | 155.98 | 156.04 | 154.32 | 156.00 | 361.00 |
| Apr 18, 2024 | 158.75 | 158.75 | 158.75 | 158.75 | 0.000 |
| Apr 17, 2024 | 156.85 | 160.52 | 156.85 | 158.75 | 313.00 |
| Apr 16, 2024 | 162.38 | 162.38 | 162.38 | 162.38 | 5.000 |
| Apr 15, 2024 | 163.69 | 163.69 | 158.98 | 162.00 | 267.00 |
| Apr 12, 2024 | 163.36 | 163.75 | 161.78 | 163.51 | 285.00 |
| Apr 11, 2024 | 163.46 | 164.90 | 161.95 | 164.90 | 41.00 |
| Apr 10, 2024 | 161.60 | 162.63 | 160.80 | 161.50 | 671.00 |
| Apr 09, 2024 | 166.80 | 168.25 | 165.10 | 168.25 | 113.00 |
| Apr 08, 2024 | 166.63 | 166.63 | 162.62 | 162.62 | 29.00 |
| Apr 05, 2024 | 167.53 | 167.90 | 160.57 | 162.00 | 205.00 |
| Apr 04, 2024 | 170.60 | 170.60 | 169.10 | 169.10 | 566.00 |
| Apr 03, 2024 | 169.41 | 173.19 | 169.41 | 171.50 | 20068.00 |
| Apr 02, 2024 | 169.25 | 169.25 | 169.25 | 169.25 | 22.00 |
| Apr 01, 2024 | 180.43 | 180.43 | 172.94 | 176.50 | 664.00 |
| Mar 28, 2024 | 178.09 | 178.15 | 175.73 | 176.81 | 617.00 |
| Mar 27, 2024 | 172.50 | 174.22 | 172.14 | 174.22 | 437.00 |
| Mar 26, 2024 | 171.38 | 173.50 | 171.38 | 172.45 | 448.00 |
| Mar 25, 2024 | 174.41 | 174.79 | 172.54 | 174.00 | 279.00 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
82.95
Minimum
Mar 18 2020
262.68
Maximum
Dec 27 2021
164.86
Average
169.13
Median
Oct 17 2022
Price Benchmarks
| Affimed NV | 5.32 |
| InflaRx NV | 1.39 |
| MorphoSys AG | 17.61 |
| BioNTech SE | 89.02 |
| Immatics NV | 10.04 |
Price Related Metrics
| PE Ratio | 23.24 |
| PS Ratio | 3.125 |
| Price to Book Value | 2.407 |
| Price to Free Cash Flow | 37.25 |
| Earnings Yield | 4.30% |
| Market Cap | 70.98B |
| Operating PE Ratio | 18.32 |
| Normalized PE Ratio | 23.37 |